These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 34114250)

  • 21. The potential use of N-methyl-3,4-methylenedioxyamphetamine (MDMA) assisted psychotherapy in the treatment of eating disorders comorbid with PTSD.
    Brewerton TD; Lafrance A; Mithoefer MC
    Med Hypotheses; 2021 Jan; 146():110367. PubMed ID: 33203569
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MDMA-assisted therapy for moderate to severe PTSD: a randomized, placebo-controlled phase 3 trial.
    Mitchell JM; Ot'alora G M; van der Kolk B; Shannon S; Bogenschutz M; Gelfand Y; Paleos C; Nicholas CR; Quevedo S; Balliett B; Hamilton S; Mithoefer M; Kleiman S; Parker-Guilbert K; Tzarfaty K; Harrison C; de Boer A; Doblin R; Yazar-Klosinski B;
    Nat Med; 2023 Oct; 29(10):2473-2480. PubMed ID: 37709999
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Durability of improvement in post-traumatic stress disorder symptoms and absence of harmful effects or drug dependency after 3,4-methylenedioxymethamphetamine-assisted psychotherapy: a prospective long-term follow-up study.
    Mithoefer MC; Wagner MT; Mithoefer AT; Jerome L; Martin SF; Yazar-Klosinski B; Michel Y; Brewerton TD; Doblin R
    J Psychopharmacol; 2013 Jan; 27(1):28-39. PubMed ID: 23172889
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for victims of sexual abuse with severe post-traumatic stress disorder: an open label pilot study in Brazil.
    Jardim AV; Jardim DV; Chaves BR; Steglich M; Ot'alora G M; Mithoefer MC; da Silveira DX; Tófoli LF; Ribeiro S; Matthews R; Doblin R; Schenberg EE
    Braz J Psychiatry; 2021; 43(2):181-185. PubMed ID: 32638920
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treating posttraumatic stress disorder with MDMA-assisted psychotherapy: A preliminary meta-analysis and comparison to prolonged exposure therapy.
    Amoroso T; Workman M
    J Psychopharmacol; 2016 Jul; 30(7):595-600. PubMed ID: 27118529
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Psychopharmacology of ±3,4 Methylenedioxymethamphetamine and its Role in the Treatment of Posttraumatic Stress Disorder.
    Amoroso T
    J Psychoactive Drugs; 2015; 47(5):337-44. PubMed ID: 26579955
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of MDMA-assisted therapy for PTSD on self-experience.
    van der Kolk BA; Wang JB; Yehuda R; Bedrosian L; Coker AR; Harrison C; Mithoefer M; Yazar-Klosinki B; Emerson A; Doblin R
    PLoS One; 2024; 19(1):e0295926. PubMed ID: 38198456
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MDMA-assisted psychotherapy for PTSD: Are memory reconsolidation and fear extinction underlying mechanisms?
    Feduccia AA; Mithoefer MC
    Prog Neuropsychopharmacol Biol Psychiatry; 2018 Jun; 84(Pt A):221-228. PubMed ID: 29524515
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [MDMA-assisted therapy for PTSD].
    Thorarinsdottir H; Gudmundsdottir B; Sigurdsson E
    Laeknabladid; 2024 May; 110(5):254-261. PubMed ID: 38713560
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effects of MDMA-assisted therapy on alcohol and substance use in a phase 3 trial for treatment of severe PTSD.
    Nicholas CR; Wang JB; Coker A; Mitchell JM; Klaire SS; Yazar-Klosinski B; Emerson A; Brown RT; Doblin R
    Drug Alcohol Depend; 2022 Apr; 233():109356. PubMed ID: 35286849
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Progress and promise for the MDMA drug development program.
    Feduccia AA; Holland J; Mithoefer MC
    Psychopharmacology (Berl); 2018 Feb; 235(2):561-571. PubMed ID: 29152674
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treating posttraumatic stress disorder and alcohol use disorder comorbidity: Current pharmacological therapies and the future of MDMA-integrated psychotherapy.
    Gully BJ; Eaton E; Capone C; Haass-Koffler CL
    J Psychopharmacol; 2023 Dec; 37(12):1182-1189. PubMed ID: 38009477
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MDMA-assisted psychotherapy for treatment of anxiety and other psychological distress related to life-threatening illnesses: a randomized pilot study.
    Wolfson PE; Andries J; Feduccia AA; Jerome L; Wang JB; Williams E; Carlin SC; Sola E; Hamilton S; Yazar-Klosinski B; Emerson A; Mithoefer MC; Doblin R
    Sci Rep; 2020 Nov; 10(1):20442. PubMed ID: 33235285
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Perceived Benefits of MDMA-Assisted Psychotherapy beyond Symptom Reduction: Qualitative Follow-Up Study of a Clinical Trial for Individuals with Treatment-Resistant PTSD.
    Barone W; Beck J; Mitsunaga-Whitten M; Perl P
    J Psychoactive Drugs; 2019; 51(2):199-208. PubMed ID: 30849288
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Imagery rehearsal therapy for chronic nightmares in sexual assault survivors with posttraumatic stress disorder: a randomized controlled trial.
    Krakow B; Hollifield M; Johnston L; Koss M; Schrader R; Warner TD; Tandberg D; Lauriello J; McBride L; Cutchen L; Cheng D; Emmons S; Germain A; Melendrez D; Sandoval D; Prince H
    JAMA; 2001 Aug; 286(5):537-45. PubMed ID: 11476655
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MDMA-Assisted Therapy for Severe PTSD: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study.
    Mitchell JM; Bogenschutz M; Lilienstein A; Harrison C; Kleiman S; Parker-Guilbert K; Ot'alora G M; Garas W; Paleos C; Gorman I; Nicholas C; Mithoefer M; Carlin S; Poulter B; Mithoefer A; Quevedo S; Wells G; Klaire SS; van der Kolk B; Tzarfaty K; Amiaz R; Worthy R; Shannon S; Woolley JD; Marta C; Gelfand Y; Hapke E; Amar S; Wallach Y; Brown R; Hamilton S; Wang JB; Coker A; Matthews R; de Boer A; Yazar-Klosinski B; Emerson A; Doblin R
    Focus (Am Psychiatr Publ); 2023 Jul; 21(3):315-328. PubMed ID: 37404971
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Trial of Prazosin for Post-Traumatic Stress Disorder in Military Veterans.
    Raskind MA; Peskind ER; Chow B; Harris C; Davis-Karim A; Holmes HA; Hart KL; McFall M; Mellman TA; Reist C; Romesser J; Rosenheck R; Shih MC; Stein MB; Swift R; Gleason T; Lu Y; Huang GD
    N Engl J Med; 2018 Feb; 378(6):507-517. PubMed ID: 29414272
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of Psychoactive Drugs for the Treatment of Posttraumatic Stress Disorder: A Systematic Review of MDMA, Ketamine, LSD and Psilocybin.
    Varker T; Watson L; Gibson K; Forbes D; O'Donnell ML
    J Psychoactive Drugs; 2021; 53(1):85-95. PubMed ID: 32931403
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The efficacy and safety of MDMA-assisted psychotherapy for treatment of posttraumatic stress disorder: A systematic review and meta-analysis from randomized controlled trials.
    Yang J; Wang N; Luo W; Gao J
    Psychiatry Res; 2024 Sep; 339():116043. PubMed ID: 38896930
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Will MDMA-assisted psychotherapy become a breakthrough in treatment-resistant post-traumatic stress disorder? A critical narrative review.
    Szafoni S; Więckiewicz G; Pudlo R; Gorczyca P; Piegza M
    Psychiatr Pol; 2022 Aug; 56(4):823-836. PubMed ID: 37074831
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.